drugset / Trial / NCT00261950
Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the effects of cinacalcet on markers of bone turnover in patients with kidney disease who are receiving dialysis.
Timeline
- Start
- 2006-05
- Primary completion
- 2011-05
- Completion
- 2011-05
Publications
- Background TBD.BONAFIDE Baseline/Primary Results.Journal-004521;
- Background Behets GJ, Spasovski G, Sterling LR, Goodman WG, Spiegel DM, De Broe ME, D'Haese PC. Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism. Kidney Int. 2015 Apr;87(4):846-56. doi: 10.1038/ki.2014.349. Epub 2014 Oct 22.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cinacalcet | Other / unclassified | 30 mg | Oral |
| Subject | Cinacalcet | Other / unclassified | 60 mg | Oral |
| Subject | Cinacalcet | Other / unclassified | 90 mg | Oral |
| Subject | Cinacalcet | Other / unclassified | 120 mg | Oral |
| Subject | Cinacalcet | Other / unclassified | 180 mg | Oral |